Abstract：Objective To investigate the risk factors of sarcopenia among the elderly, so as to provide insights into prevention of sarcopenia among the elderly. Methods A case-control study was conducted. A total of 371 patients with sarcopenia at ages of 60 years and older admitted to the First Affiliated Hospital of Xinjiang Medical University were selected as the case group, while 1∶1 matching healthy volunteers by gender, age and ethnicity in the hospital during the study period served as controls. Participants' demographics, disease history and nutrition were collected using questionnaire surveys, and factors affecting the development of sarcopenia were identified using a multivariable conditional logistic regression model. Results Participants in the case group included 171 men (46.09%), 254 Han ethnic populations (68.46%) and had a mean age of (73.04±7.83) years. Univariable conditional logistic regression analysis showed that participants with smoking, alcohol consumption, hypertension, diabetes, dyslipidemia, thyroid dysfunction and malnutrition had higher risk of developing sarcopenia (all P<0.05). Multivariable conditional logistic regression analysis identified hypertension (OR=1.851, 95%CI: 1.344-2.549), diabetes (OR=1.537, 95%CI: 1.068-2.213), dyslipidemia (OR=1.542, 95%CI: 1.112-2.140) and thyroid dysfunction (OR=2.575, 95%CI: 1.838-3.609) as risk factors of sarcopenia among the elderly. Conclusion Hypertension, diabetes, dyslipidemia and thyroid dysfunction may be risk factors of sarcopenia among the elderly.
张媛, 韩正风, 马艳. 老年人群肌少症危险因素的病例对照研究[J]. 预防医学, 2023, 35(6): 461-464.
ZHANG Yuan, HAN Zhengfeng, MA Yan. Risk factors of sarcopenia among the elderly: a case-control study. Preventive Medicine, 2023, 35(6): 461-464.
[1] JONES C,CHEN K M,WEEKS B,et al.Healthy beat acupunch exercise program:validation and feasibility study for older adults with reduced physical capacity or probable sarcopenia[J].Explore,2021,17(6):498-504. [2] LEE S Y,TUNG H H,LIU C Y,et al.Physical activity and sarcopenia in the geriatric population:a systematic review[J].J Am Med Dir Assoc,2018,19(5):378-383. [3] CHEN L K,LIU L K,WOO J,et al.Sarcopenia in Asia:consensus report of the Asian Working Group for Sacopenia[J].J Am Med Dir Assoc,2014,15(2):95-101. [4] 车雅洁,杨璇璇,张可,等.乌鲁木齐市社区老年人肌少症患病现状及相关因素[J].中华骨质疏松和骨矿盐疾病杂志,2020,13(4):304-310. [5] 汪亚男,宋红玲,顾艳荭,等.老年2型糖尿病患者合并肌少症影响因素分析[J].预防医学,2019,31(6):582-585. [6] 中华医学会骨质疏松和骨矿盐疾病分会.肌少症共识[J].中华骨质疏松和骨矿盐疾病杂志,2016,9(3):215-227. [7] KONDRUP J,RASMUSSEN H H,HAMBERG O L E,et al.Nutritional risk screening(NRS 2002):a new method based on an analysis of controlled clinical trials[J].Clin Nutr,2003,22(3):321-336. [8] 万学红,卢雪峰.诊断学[M].9版.北京:人民卫生出版社,2018:50-53. [9] 《中国高血压防治指南》修订委员会.中国高血压防治指南(2018年修订版)[J].心脑血管病防治,2019,19(1):1-43. [10] 中国老年2型糖尿病防治临床指南编写组,中国老年医学学会老年内分泌代谢分会,中国老年保健医学研究会老年内分泌与代谢分会,等.中国老年2型糖尿病防治临床指南(2022年版)[J].中华内科杂志,2022,61(1):12-50. [11] 诸骏仁,高润霖,赵水平,等.中国成人血脂异常防治指南(2016年修订版)[J].中华健康管理学杂志,2017,11(1):7-28. [12] 中国医师协会肾脏内科医师分会.中国肾脏疾病高尿酸血症诊治的实践指南(2017版)[J].中华医学杂志,2017,97(25):1927-1936. [13] 黄榕翀,郭宏洲.《2019欧洲心脏病学会慢性冠脉综合征的诊断和管理指南》解读[J].实用心脑肺血管病杂志,2019,27(10):1-5. [14] 中华医学会内分泌学分会,《中国心血管健康与疾病报告2019》编写组.中国甲状腺疾病诊治指南:甲状腺疾病的实验室及辅助检查[J].中华内科杂志,2007,46(8):697-702. [15] HUANG K,YANG T,XU J,et al.Prevalence,risk factors,and management of asthma in China:a national cross-sectional study[J].Lancet,2019,394(10196):407-418. [16] 阮春燕,林俏丽,蔡倩,等.饮酒与慢性阻塞性肺疾病风险关系的meta分析[J].实用预防医学,2022,29(11):1328-1332. [17] 杨晨,何华娟,李建蒲,等.原发性高血压合并肌少症患病率及影响因素分析[J].中国全科医学,2022,25(35):4381-4388. [18] MARZETTI E,CALVANI R,CESARI M,et al.Mitochondrial dysfunction and sarcopenia of aging:from signaling pathways to clinical trials[J].Int J Biochem Cell Bio,2013,45(10):2288-2301. [19] FAN J,KOU X,JIA S,et al.Autophagy as a potential target for sarcopenia[J].J Cell Physiol,2016,231(7):1450-1459. [20] 蒋翠萍,邱婕萸真,陶晓明,等.中老年住院2型糖尿病患者肌少症发生率及相关危险因素分析[J].老年医学与保健,2021,27(6):1282-1286. [21] SRIKANTHAN P,HEVENER A L,KARLAMANGLA A S.Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia:findings from the national health and nutrition examination survey Ⅲ[J/OL].PLoS One,2010,5(5)[2023-05-11].https://doi.org/10.1371/journal.pone.0010805. [22] SHENG Y,MA D,ZHOU Q,et al.Association of thyroid function with sarcopenia in elderly Chinese euthyroid subjects[J].Aging Clin Exp Res,2019,31(8):1113-1120. [23] 王玲,沈芸.甲状腺功能与老年衰弱的相关性[J].中国老年保健医学,2020,18(4):120-122. [24] CLEGG A,HASSAN-SMITH Z.Frailty and the endocrine system[J].Lancet Diabetes Endo,2018,6(9):743-752.
